Mentice receives order of total SEK 7.0 million from Edwards Lifesciences
Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from Edwards Lifesciences for the segment Medical Device Industry relating to solutions for the Mitral/Tricuspid Valve therapy areas. The order covers system sales and development to be delivered during the fourth quarter 2020. The total order value amounts to SEK 7.0 million and will be accounted for in the order book for the third quarter 2020. Mentice receives order from Edwards Lifesciences (EW) (Irvine, CA) relating to